These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15570303)

  • 1. Anti-CD20 monoclonal antibody rituximab for the treatment of B-cell chronic lymphocytic leukemia-associated pure red cell aplasia.
    Pantelidou D; Tsatalas C; Margaritis D; Kaloutsi V; Spanoudakis E; Bourikas G
    Hematol J; 2004; 5(6):546-7. PubMed ID: 15570303
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful response to rituximab in a patient with pure red cell aplasia complicating chronic lymphocytic leukaemia.
    Batlle M; Ribera JM; Oriol A; Plensa E; Millá F; Feliu E
    Br J Haematol; 2002 Sep; 118(4):1192-3. PubMed ID: 12199808
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pure red cell aplasia associated with chronic lymphocytic leukaemic successfully treated with rituximab].
    Jiménez-Gonzalo FJ; Ríos-Herranz E; García-Donas Gabaldón G
    Med Clin (Barc); 2005 Nov; 125(18):717-8. PubMed ID: 16324487
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of rituximab in the treatment of refractory chronic lymphocytic leukemia patient with bone marrow aplasia.
    Marotta G; Lenoci M; Fabbri A; Tozzi M; Lauria F
    Hematol J; 2002; 3(6):299-301. PubMed ID: 12522452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: report of two cases and review of the literature.
    Narra K; Borghaei H; Al-Saleem T; Höglund M; Smith MR
    Leuk Res; 2006 Jan; 30(1):109-14. PubMed ID: 16043218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pure red cell aplasia complicating B cell small lymphocytic lymphoma: a case report.
    Vlachaki E; Tselios K; Charalambidou S; Ioannidou E; Klonizakis I
    Int J Hematol; 2008 Oct; 88(3):341-342. PubMed ID: 18766306
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe anemia caused by combination of autoimmune hemolysis, pure red cell aplasia and massive bone marrow infiltration in an elderly patient with chronic lymphocytic leukemia: successful treatment with rituximab.
    Smolej L; Belada D; Cermanová M; Maisnar V; Lunáková E
    Leuk Res; 2010 May; 34(5):e140-1. PubMed ID: 20053448
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia.
    Ghazal H
    Blood; 2002 Feb; 99(3):1092-4. PubMed ID: 11807020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia.
    Zecca M; De Stefano P; Nobili B; Locatelli F
    Blood; 2001 Jun; 97(12):3995-7. PubMed ID: 11389047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful resumption of epoetin alfa after rituximab treatment in a patient with pure red cell aplasia.
    Mandreoli M; Finelli C; Lopez A; Ascani S; Vianelli N; Baccarani M; Santoro A
    Am J Kidney Dis; 2004 Oct; 44(4):757-61. PubMed ID: 15384028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of ofatumumab against rituximab-resistant B-CLL/SLL cells with low CD20 protein expression.
    Shimada K; Tomita A; Saito S; Kiyoi H
    Br J Haematol; 2014 Aug; 166(3):455-7. PubMed ID: 24673649
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pure red cell aplasia, associated with chronic lymphoid leukemia, successfully treated with closorine].
    Rácz K; Telek B; Ujj G; Kiss A; Rák K; Udvardy M
    Orv Hetil; 1997 Nov; 138(45):2883-7. PubMed ID: 9432638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory pure red-cell aplasia associated with B chronic lymphocytic leukemia successfully treated by fludarabine.
    Sandra S; Real E; Pastor E; Grau E
    Haematologica; 1999 Dec; 84(12):1154-5. PubMed ID: 10586218
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of red cell aplasia in CLL with fludarabine.
    Ribeiro I; Tsatalas C; Catovsky D
    Leukemia; 1999 Nov; 13(11):1897. PubMed ID: 10557069
    [No Abstract]   [Full Text] [Related]  

  • 15. Campath-1H induced pure red cell aplasia in a patient with chronic lymphatic leukaemia.
    Thachil J; Salim R
    Leuk Res; 2007 Jul; 31(7):1025-6. PubMed ID: 17005249
    [No Abstract]   [Full Text] [Related]  

  • 16. Level of CD 20-expression and efficacy of rituximab treatment in patients with resistant or relapsing B-cell prolymphocytic leukemia and B-cell chronic lymphocytic leukemia.
    Perz J; Topaly J; Fruehauf S; Hensel M; Ho AD
    Leuk Lymphoma; 2002 Jan; 43(1):149-51. PubMed ID: 11908720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment and re-treatment of resistant B-cell chronic lymphocytic leukemia with the monoclonal anti-CD 20 antibody rituximab.
    Herold M; Schulze A; Härtwig K; Anger G
    Ann Hematol; 2000 Jun; 79(6):332-5. PubMed ID: 10901614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of fresh frozen plasma as a source of complement to rituximab in advanced chronic lymphocytic leukaemia.
    Klepfish A; Schattner A; Ghoti H; Rachmilewitz EA
    Lancet Oncol; 2007 Apr; 8(4):361-2. PubMed ID: 17395110
    [No Abstract]   [Full Text] [Related]  

  • 19. Autoimmune cytopenias in chronic lymphocytic leukemia.
    D'Arena G; Guariglia R; La Rocca F; Trino S; Condelli V; De Martino L; De Feo V; Musto P
    Clin Dev Immunol; 2013; 2013():730131. PubMed ID: 23690826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic lymphocytic leukemia-associated pure red cell aplasia.
    D'Arena G; Cascavilla N
    Int J Immunopathol Pharmacol; 2009; 22(2):279-86. PubMed ID: 19505381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.